Accessibility Menu
NewGenIvf Group logo

NewGenIvf Group(NASDAQ) NIVF

Market Cap$3.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-100%
1 Month-38%
$1.04
-5.46%
-0.06Today
NewGenIvf Group last closing stock price
MetricPriceDate
Last closeUSD 1.052026-07-27
NewGenIvf Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-19.85%USD 1.312026-07-20
1 month-37.5%USD 1.682026-06-26
3 month-81.58%USD 5.702026-04-28
Year to date-95.77%USD 24.842025-12-31
1 year-99.78%USD 468.002025-07-25
3 year-100%USD 1,909,800.002023-07-25
Since inception-100%USD 1,769,385.842022-03-18

NewGenIvf Group Financials at a Glance

Market Cap

$3.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.45M

Net Income (TTM)

$9.03M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.04

Volume

5,889

Open

$1.07

Previous Close

$1.04

Daily Range

$1.02 - $1.10

52-Week Range

$1.01 - $568.53

Estimated Earnings Date

Jul 30, 2026

NIVF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About NewGenIvf Group

NewGenIvf Group Limited is a healthcare company based in Bangkok, Thailand, specializing in assisted reproductive services. The firm is dedicated to providing a range of fertility treatments, including in-vitro fertilization (IVF), egg donation, and surrogacy, supported by comprehensive ancillary care.

Products and Services
  • Conventional in-vitro fertilization (IVF) services
  • Egg donation programs
  • Surrogacy arrangements and support
Growth Outlook
  • Revenue increased to $1,424,554 in Q4 2025, showing growth potential
  • Gross profit margin improved to 36.8% in Q4 2025
  • Strong demand for fertility services in Southeast Asia supports expansion
Financial Highlights
  • Trailing twelve months (TTM) revenue of $5,000,000 indicates a solid revenue base
  • Current ratio of 3.12 suggests strong liquidity position
  • Net income margin of 3.38% reflects operational efficiency
NewGenIvf Group Limited operates in a growing market, driven by increasing demand for fertility treatments. The company's recent financial performance indicates a positive trajectory, with significant revenue growth and improved gross profit margins. The strong liquidity position, as evidenced by a current ratio of 3.12, provides a buffer for operational needs and potential investments. The firm’s commitment to expanding its service offerings aligns with the rising demand for assisted reproductive technologies in Southeast Asia, positioning it well for future growth.
AI Generated • Jul 24, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

76

CEO

Wing Fung Siu

Website

www.newgenivf.com

Headquarters

Bangkok, BM 10110, TH

NIVF Financials

Key Financial Metrics (TTM)

Gross Margin

23.72%

Operating Margin

-276.57%

Net Income Margin

338.20%

Return on Equity

32.69%

Return on Capital

-34.06%

Return on Assets

27.98%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.42M

Volume

5.89K

Avg. Volume

2.05M

Financials (TTM)

Gross Profit

$1.83M

Operating Income

-$8.36M

EBITDA

$9.81M

Operating Cash Flow

-$6.73M

Capital Expenditure

-$2.82K

Free Cash Flow

-$6.74M

Cash & ST Invst.

$758.62K

Total Debt

$4.86M

NewGenIvf Group Performance Analysis

NewGenIvf Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 5,136,153N/A
20242024-12-31USD 5,433,3755.8%
20252025-12-31USD 4,726,433-13.0%
NewGenIvf Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30N/A
Q42024-12-31-13.5%
Q32025-09-30N/A
Q42025-12-3111.1%
NewGenIvf Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 11,631.60N/A
20232023-12-31USD 2,309.40-80.1%
20242024-12-31USD -4,147.20N/A
20252025-12-31USD 9.12N/A
NewGenIvf Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32024-09-30N/A
Q42024-12-31-251.9%
Q32025-09-30N/A
Q42025-12-31-145.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.42M

-6.2%

Gross Profit

$524.03K

+166.2%

Gross Margin

36.79%

N/A

Market Cap

$3.76MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$43.24K

N/A

Employees

87

N/A

Net Income

-$7.67M

-703.0%

EBITDA

-$7.27M

-1709.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$758.62K

+1302.2%

Total Debt

$4.86M

+1362.6%

Accounts Receivable

$1.07M

+105.8%

Inventory

$335.36K

+165.6%

Long Term Debt

$4.37M

+3572.7%

Short Term Debt

$494.16K

+131.4%

Return on Assets

27.98%

N/A

Return on Invested Capital

-24.66%

N/A

Free Cash Flow

-$6.36M

-27903.3%

Operating Cash Flow

-$6.35M

-27890.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IVFINVO Fertility, Inc.
$0.96-4.09%
CDTCDT Equity Inc.
$2.85-7.03%
ZVSAZyVersa Therapeutics, Inc.
$0.12+0.00%
HEPAHepion Pharmaceuticals, Inc.
$0.07+21.50%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.24-0.02%

Questions About NIVF

What is the current price of NewGenIvf Group?

NewGenIvf Group is trading at $1.04 per share.

What is the 52-week range for NewGenIvf Group?

Over the past 52 weeks, NewGenIvf Group has traded between $1.01 and $568.53.

How much debt does NewGenIvf Group have?

As of the most recent reporting period, NewGenIvf Group reported total debt of $3.03M.

How much cash does NewGenIvf Group have on hand?

NewGenIvf Group reported $457.74K in cash and cash equivalents in its most recent financial results.

What is NewGenIvf Group’s dividend yield?

NewGenIvf Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services